- Arm targets $50-55 billion valuation for Nasdaq listing.
- Amgen settles FTC challenge to Horizon Therapeutics acquisition.
- Australian lithium producer Liontown Resources backs Albemarle's $4.3 billion bid.
- Lloyds Banking Group is in talks with the Barclay family and US private equity firm Carlyle to acquire Very Group.
- Novo Nordisk launches its weight-loss drug Wegovy in the UK.
- BMW forecasts an increase in sales in China in 2023, according to its CFO.
- Nestlé sells Palforzia, its peanut allergy treatment business, to Stallergenes Greer.
- Novartis sues the US government over drug price regulation.
- Cosmo Pharmaceuticals changes partner for Rifamycin SV MMX.
- Flughafen Zürich confirms its medium- and long-term financial targets.
- Hexatronic acquires New Zealand-based ATG Technology.
- Italian government may accelerate sale of its stake in Banca Monte dei Paschi di Siena.
- Encavis obtains a 180 million euro revolving credit facility.
- London Stock Exchange Group to create new blockchain-based digital markets unit.